Emergence and spread of a new community-genotype methicillin-resistant Staphylococcus aureus clone in Colombia

Javier Escobar-Perez1, Niradiz Reyes2, Ricaurte Alejandro Marquez-Ortiz3

  • 1Bacterial Molecular Genetics Laboratory, Universidad El Bosque, Carrera 9 #131A-02, 110121274, Bogotá, DC, Colombia. javiesco21@yahoo.com.

BMC Infectious Diseases
|February 2, 2017
PubMed
Abstract

Insights

A new community-genotype methicillin-resistant Staphylococcus aureus (CG-MRSA) clone, COL923, has emerged in Colombia. This antibiotic-resistant clone exhibits novel genetic structures and is spreading across multiple cities.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Community-genotype methicillin-resistant Staphylococcus aureus (CG-MRSA) poses a global health threat due to its resistance and virulence.
  • CG-MRSA infections affect both hospitalized patients and healthy individuals in the community.

Purpose of the Study:

  • To characterize a newly identified CG-MRSA clone (COL923) circulating in Colombia.
  • To investigate the molecular and genetic features of this emerging clone.

Main Methods:

  • Multilocus sequence typing (MLST)
  • Pulsed-field gel electrophoresis (PFGE)
  • SCCmec, agr, and spa typing
  • Whole-genome sequencing (WGS)

Main Results:

  • All 32 isolates belonged to ST923 (CC8), harbored SCCmec IVa, spa type t1635, and lacked an arginine catabolism mobile element.
  • The COL923 clone showed resistance to non-beta-lactam antibiotics, macrolides, and tetracyclines.
  • WGS revealed novel prophage 3 and beta-island structures, and a distinct pathogenicity island 5, differentiating COL923 from USA300.

Conclusions:

  • The COL923 clone has emerged and is spreading in multiple Colombian cities.
  • This clone exhibits significant antibiotic resistance and unique genetic mobile elements.
  • COL923 represents a distinct clade compared to other well-known MRSA strains like USA300.